Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05617313
Title Study of GT103 in Combination With Pembrolizumab in Refractory, Metastatic Non-Small Cell Lung Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Jeffrey Clarke
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Illinois Cancer Center Chicago Illinois 60612 United States Details
Indiana University Melvin and Bren Simon Comprehensive Cancer Center Indianapolis Indiana 46202 United States Details
Karmanos Cancer Center (Wayne State University) Detroit Michigan 48201 United States Details
Summit Health Berkeley Heights New Jersey 07922 United States Details
Duke Cancer Institute Durham North Carolina 27710 United States Details
University of Virginia Health System Charlottesville Virginia 22908 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field